GGrantIndex
Sort

21,453 grants matching tuberculosis

Core B: Animal Model Core

$468,908
Veronique Dartois · Weill Medical Coll Of Cornell Univ · P01 · FY2022 · AI

HIV/TB Interaction in the Lung

$468,819
Michael D. Weiden · New York University School Of Medicine · R01 · FY2007 · HL

Human Genetic Dissection of Exit from Latency in Tuberculosis

$468,805
Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2014 · AI

HIV/TB Interaction in the Lung

$468,751
Michael D. Weiden · New York University School Of Medicine · R01 · FY2006 · HL

M. tuberculosis strain-dependent interactions with host cells

$468,684
Jeffery S Cox · University Of Washington · U19 · FY2025 · AI

Measure the metabolic and genetic factors that determine M. Tuberculosis

$468,635
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2018 · AI

M. tuberculosis Infection in the Lung

$468,534
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2007 · HL

Molecular Mechanisms of Transcription Initiation and DNA Repair

$468,500
Eric A Galburt · Washington University · R35 · FY2023 · GM

Initiation of the Immune Response to M. tuberculosis

$468,481
New York University School Of Medicine · R01 · FY2005 · AI

Biomarkers to Stratify Risk of Progression from Latent TB Infection to Active

$468,455
Padmini Salgame · Boston Medical Center · U19 · FY2015 · AI

Beyond SABOR: A Border Embedded Health Promotion

$468,348
Elena M Bastida · University Of North Texas Hlth Sci Ctr · R24 · FY2008 · MD

Controlled Photochemical Release of Nitric Oxide for Biomedical Applications

$468,336
Steven P. Schwendeman · University Of Michigan At Ann Arbor · R01 · FY2022 · EB

Human T Cell Antigens of Mycobacterium tuberculosis

$468,275
Steven G. Reed · Access To Advanced Health Institute · R01 · FY2006 · AI

DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D

$468,208
Yale University · R01 · FY2003 · DA

Chemical Mycobateriology

$468,201
Carolyn R Bertozzi · Stanford University · R37 · FY2017 · AI

Project 3 Determinants of Vaccine Efficacy

$468,043
Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · P01 · FY2025 · AI

Understanding How the Ubiquitin Ligase CBL Regulates Innate Immune Responses

$467,974
Bennett Penn · University Of California At Davis · R01 · FY2023 · AI

Continuity of Care for Drug-Addicted Offenders in RI

$467,942
Rhode Island Hospital (Providence, Ri) · U01 · FY2002 · DA

Mathematical Modeling Core

$467,912
Stephan Schmidt · University Of Florida · P01 · FY2016 · AI

Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine

$467,889
Shabaana A. Khader · Washington University · R61 · FY2022 · AI

Using Single Cell Biological Approaches to Understand CNS TB

$467,875
Chris G Dulla · Tufts University Boston · R01 · FY2024 · NS

Using Single Cell Biological Approaches to Understand CNS TB

$467,875
Chris G Dulla · Tufts University Boston · R01 · FY2025 · NS

Qualification of Assays to Measure Human T-cell Responses Against Mycobacterial Lipid Antigens

$467,872
Chetan Seshadri · University Of Washington · R01 · FY2018 · AI

SELF-SPLICING INTEINS: FUNCTION, EVOLUTION, APPLICATION

$467,818
Marlene Belfort · State University Of New York At Albany · R01 · FY2013 · GM

CD4 T Cells in Tuberculosis

$467,797
University Of Pittsburgh At Pittsburgh · R01 · FY2002 · AI